Apogee Accounts Payable vs Total Stockholder Equity Analysis

APGE Stock   52.02  5.76  12.45%   
Apogee Therapeutics, financial indicator trend analysis is way more than just evaluating Apogee Therapeutics, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apogee Therapeutics, is a good investment. Please check the relationship between Apogee Therapeutics, Accounts Payable and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Accounts Payable vs Total Stockholder Equity

Accounts Payable vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apogee Therapeutics, Accounts Payable account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Apogee Therapeutics,'s Accounts Payable and Total Stockholder Equity is 0.95. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Apogee Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of Apogee Therapeutics,'s Accounts Payable and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Apogee Therapeutics, Common are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Accounts Payable i.e., Apogee Therapeutics,'s Accounts Payable and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.95
Relationship DirectionPositive 
Relationship StrengthVery Strong

Accounts Payable

An accounting item on the balance sheet that represents Apogee Therapeutics, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Apogee Therapeutics, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Apogee Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apogee Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
As of December 4, 2024, Selling General Administrative is expected to decline to about 15.1 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 266 M
 2010 2023 2024 (projected)
Depreciation And Amortization33.5M9.0M17.0M
Interest Income92K9.0M5.0M

Apogee Therapeutics, fundamental ratios Correlations

1.01.00.960.99-0.961.0-0.921.0-0.991.01.01.01.01.01.0-0.83-0.83-0.83-0.83
1.01.00.981.0-0.971.0-0.951.0-1.00.991.01.01.01.01.0-0.86-0.86-0.86-0.86
1.01.00.970.99-0.961.0-0.931.0-0.991.01.01.01.01.01.0-0.84-0.84-0.84-0.84
0.960.980.970.99-1.00.95-0.990.96-0.990.950.970.970.960.960.96-0.95-0.95-0.95-0.95
0.991.00.990.99-0.990.98-0.970.99-1.00.980.990.990.980.990.99-0.91-0.91-0.91-0.91
-0.96-0.97-0.96-1.0-0.99-0.950.99-0.960.99-0.94-0.97-0.96-0.95-0.96-0.960.950.950.950.95
1.01.01.00.950.98-0.95-0.911.0-0.991.01.01.01.01.01.0-0.81-0.81-0.81-0.81
-0.92-0.95-0.93-0.99-0.970.99-0.91-0.920.97-0.91-0.94-0.93-0.92-0.92-0.920.980.980.980.98
1.01.01.00.960.99-0.961.0-0.92-0.991.01.01.01.01.01.0-0.83-0.83-0.83-0.83
-0.99-1.0-0.99-0.99-1.00.99-0.990.97-0.99-0.98-1.0-0.99-0.99-0.99-0.990.890.890.890.89
1.00.991.00.950.98-0.941.0-0.911.0-0.981.01.01.01.01.0-0.8-0.8-0.8-0.8
1.01.01.00.970.99-0.971.0-0.941.0-1.01.01.01.01.01.0-0.84-0.84-0.84-0.84
1.01.01.00.970.99-0.961.0-0.931.0-0.991.01.01.01.01.0-0.84-0.84-0.84-0.84
1.01.01.00.960.98-0.951.0-0.921.0-0.991.01.01.01.01.0-0.82-0.82-0.82-0.82
1.01.01.00.960.99-0.961.0-0.921.0-0.991.01.01.01.01.0-0.83-0.83-0.83-0.83
1.01.01.00.960.99-0.961.0-0.921.0-0.991.01.01.01.01.0-0.83-0.83-0.83-0.83
-0.83-0.86-0.84-0.95-0.910.95-0.810.98-0.830.89-0.8-0.84-0.84-0.82-0.83-0.831.01.01.0
-0.83-0.86-0.84-0.95-0.910.95-0.810.98-0.830.89-0.8-0.84-0.84-0.82-0.83-0.831.01.01.0
-0.83-0.86-0.84-0.95-0.910.95-0.810.98-0.830.89-0.8-0.84-0.84-0.82-0.83-0.831.01.01.0
-0.83-0.86-0.84-0.95-0.910.95-0.810.98-0.830.89-0.8-0.84-0.84-0.82-0.83-0.831.01.01.0
Click cells to compare fundamentals

Apogee Therapeutics, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Apogee Therapeutics, is a strong investment it is important to analyze Apogee Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Apogee Therapeutics,'s future performance. For an informed investment choice regarding Apogee Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apogee Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apogee Therapeutics,. If investors know Apogee will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apogee Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.43)
Return On Assets
(0.19)
Return On Equity
(0.26)
The market value of Apogee Therapeutics, is measured differently than its book value, which is the value of Apogee that is recorded on the company's balance sheet. Investors also form their own opinion of Apogee Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Apogee Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apogee Therapeutics,'s market value can be influenced by many factors that don't directly affect Apogee Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apogee Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Apogee Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apogee Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.